Form D · Biotechnology
Scioto Biosciences, Inc.
Indianopolis, IN · CIK 0001739633
Offering snapshot reported May 8, 2018 · SEC filing
- Reported sold
- $1.82M Offering amount: $4.03M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 23, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2018 | Initial | $1,822,256 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-311852
Source: Form D, filed May 8, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Heiman | Executive |
| Kevin Meyer | Executive |
| James Schulz | Director, Executive |
| Joseph Trebley | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Noyes Pavilion 5 Th Floor E504 1800 N. Capitol Avenue
Indianopolis, IN, 46202
Indianopolis, IN, 46202